Invention Grant
- Patent Title: Antibody molecules having specificity for human IL-1β
- Patent Title (中): 对人IL-1β具有特异性的抗体分子
-
Application No.: US10544911Application Date: 2004-02-06
-
Publication No.: US07608694B2Publication Date: 2009-10-27
- Inventor: Alastair David Griffiths Lawson , Andrew George Popplewell
- Applicant: Alastair David Griffiths Lawson , Andrew George Popplewell
- Applicant Address: BE Brussels
- Assignee: UCB Pharma S.A.
- Current Assignee: UCB Pharma S.A.
- Current Assignee Address: BE Brussels
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: GB0303337.0 20030213
- International Application: PCT/GB2004/000463 WO 20040206
- International Announcement: WO2004/072116 WO 20040826
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C12P21/08 ; A61K39/395 ; C12P21/04
Abstract:
The invention relates to an antibody molecule having specificity for antigenic determinants of IL-1β, therapeutic uses of the antibody molecule and methods for producing said antibody molecule.
Public/Granted literature
- US20060228358A1 Antibody molecules having specificity for human il-1 beta Public/Granted day:2006-10-12
Information query
